Expression and alternative splicing of fibronectin mRNA in human diploid endothelial cells during aging in vitro

Franco Pagani, Laura Zagato, Jeanette A M Maier, Giovanni Ragnotti, Domenico A. Coviello, Carlo Vergani

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Different mRNAs for fibronectin arise from the variable processing of a single primary transcript. We used ribonuclease protection assay to investigate the changes occurring in fibronectin expression and the alternative splicing of mRNA precursor during aging in vitro of human diploid endothelial cells. Senescent endothelial cells release more protein and contain 4-5-fold more fibronectin mRNA than young cells. The pattern of alternative splicing of fibronectin mRNA, with the EDA and the CS1 segments largely included (35% and 77%, respectively) and the EDB segment undetectable, correlates well with previous studies at the protein level both in vitro and in vivo. No changes in the splicing pattern of fibronectin mRNA precursor were detected during endothelial cellular senescence. The increased expression of fibronectin in senescent cells may be a result of the activity of interleukin-1 α, which is overexpressed in senescent endothelial cells. It could be also important in vivo during aging and in atherosclerotic lesions.

Original languageEnglish
Pages (from-to)172-178
Number of pages7
JournalBBA - Gene Structure and Expression
Volume1173
Issue number2
DOIs
Publication statusPublished - May 28 1993

Fingerprint

Cell Aging
Endothelial cells
Alternative Splicing
Diploidy
Fibronectins
Endothelial Cells
Aging of materials
Messenger RNA
RNA Precursors
Ribonucleases
Interleukin-1
In Vitro Techniques
Assays
Proteins
Processing

Keywords

  • (Human)
  • Alternative splicing
  • Cellular senescence
  • Endothelial cell
  • Fibronectin

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Genetics
  • Structural Biology

Cite this

Expression and alternative splicing of fibronectin mRNA in human diploid endothelial cells during aging in vitro. / Pagani, Franco; Zagato, Laura; Maier, Jeanette A M; Ragnotti, Giovanni; Coviello, Domenico A.; Vergani, Carlo.

In: BBA - Gene Structure and Expression, Vol. 1173, No. 2, 28.05.1993, p. 172-178.

Research output: Contribution to journalArticle

Pagani, Franco ; Zagato, Laura ; Maier, Jeanette A M ; Ragnotti, Giovanni ; Coviello, Domenico A. ; Vergani, Carlo. / Expression and alternative splicing of fibronectin mRNA in human diploid endothelial cells during aging in vitro. In: BBA - Gene Structure and Expression. 1993 ; Vol. 1173, No. 2. pp. 172-178.
@article{342f3f1e81f2473a980075d1d8af99ff,
title = "Expression and alternative splicing of fibronectin mRNA in human diploid endothelial cells during aging in vitro",
abstract = "Different mRNAs for fibronectin arise from the variable processing of a single primary transcript. We used ribonuclease protection assay to investigate the changes occurring in fibronectin expression and the alternative splicing of mRNA precursor during aging in vitro of human diploid endothelial cells. Senescent endothelial cells release more protein and contain 4-5-fold more fibronectin mRNA than young cells. The pattern of alternative splicing of fibronectin mRNA, with the EDA and the CS1 segments largely included (35{\%} and 77{\%}, respectively) and the EDB segment undetectable, correlates well with previous studies at the protein level both in vitro and in vivo. No changes in the splicing pattern of fibronectin mRNA precursor were detected during endothelial cellular senescence. The increased expression of fibronectin in senescent cells may be a result of the activity of interleukin-1 α, which is overexpressed in senescent endothelial cells. It could be also important in vivo during aging and in atherosclerotic lesions.",
keywords = "(Human), Alternative splicing, Cellular senescence, Endothelial cell, Fibronectin",
author = "Franco Pagani and Laura Zagato and Maier, {Jeanette A M} and Giovanni Ragnotti and Coviello, {Domenico A.} and Carlo Vergani",
year = "1993",
month = "5",
day = "28",
doi = "10.1016/0167-4781(93)90178-G",
language = "English",
volume = "1173",
pages = "172--178",
journal = "Biochimica et Biophysica Acta - Gene Structure and Expression",
issn = "0167-4781",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Expression and alternative splicing of fibronectin mRNA in human diploid endothelial cells during aging in vitro

AU - Pagani, Franco

AU - Zagato, Laura

AU - Maier, Jeanette A M

AU - Ragnotti, Giovanni

AU - Coviello, Domenico A.

AU - Vergani, Carlo

PY - 1993/5/28

Y1 - 1993/5/28

N2 - Different mRNAs for fibronectin arise from the variable processing of a single primary transcript. We used ribonuclease protection assay to investigate the changes occurring in fibronectin expression and the alternative splicing of mRNA precursor during aging in vitro of human diploid endothelial cells. Senescent endothelial cells release more protein and contain 4-5-fold more fibronectin mRNA than young cells. The pattern of alternative splicing of fibronectin mRNA, with the EDA and the CS1 segments largely included (35% and 77%, respectively) and the EDB segment undetectable, correlates well with previous studies at the protein level both in vitro and in vivo. No changes in the splicing pattern of fibronectin mRNA precursor were detected during endothelial cellular senescence. The increased expression of fibronectin in senescent cells may be a result of the activity of interleukin-1 α, which is overexpressed in senescent endothelial cells. It could be also important in vivo during aging and in atherosclerotic lesions.

AB - Different mRNAs for fibronectin arise from the variable processing of a single primary transcript. We used ribonuclease protection assay to investigate the changes occurring in fibronectin expression and the alternative splicing of mRNA precursor during aging in vitro of human diploid endothelial cells. Senescent endothelial cells release more protein and contain 4-5-fold more fibronectin mRNA than young cells. The pattern of alternative splicing of fibronectin mRNA, with the EDA and the CS1 segments largely included (35% and 77%, respectively) and the EDB segment undetectable, correlates well with previous studies at the protein level both in vitro and in vivo. No changes in the splicing pattern of fibronectin mRNA precursor were detected during endothelial cellular senescence. The increased expression of fibronectin in senescent cells may be a result of the activity of interleukin-1 α, which is overexpressed in senescent endothelial cells. It could be also important in vivo during aging and in atherosclerotic lesions.

KW - (Human)

KW - Alternative splicing

KW - Cellular senescence

KW - Endothelial cell

KW - Fibronectin

UR - http://www.scopus.com/inward/record.url?scp=0027289746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027289746&partnerID=8YFLogxK

U2 - 10.1016/0167-4781(93)90178-G

DO - 10.1016/0167-4781(93)90178-G

M3 - Article

VL - 1173

SP - 172

EP - 178

JO - Biochimica et Biophysica Acta - Gene Structure and Expression

JF - Biochimica et Biophysica Acta - Gene Structure and Expression

SN - 0167-4781

IS - 2

ER -